Search Medical Condition
Please enter condition
Please choose location from dropdown
Clear Trial Filters

High Blood Pressure (Hypertension) Clinical Trials

A listing of High Blood Pressure (Hypertension) medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

RESULTS

Found (8) clinical trials

The purpose of the RADIANCE-HTN study is to demonstrate the ability of the Paradise System to effectively reduce systolic daytime ambulatory BP (ABP) in hypertensive subjects. In addition the study is designed to document the safety profile of the Paradise System in all treated subjects.

Phase N/A

Guiding Hypertension Management Using Different Blood Pressure Monitoring Strategies

The traditional BP used for clinical practice, the office BP, is usually measured in a busy and hurry clinical environment, and interfered by the well-known confounding whitecoat effect. As such, unattended automated office BP monitoring (uAOBP) has been proposed as an effective solution and further promoted by Canadian physicians. Nonetheless, ...

Phase N/A

Hypertension Management in Family Practice

This a retrospective cross-sectional chart review study. The study population will consist of a random sample of patients from the Family Practice of the LSU Department of Family Medicine at LSU Health Sciences Center in New Orleans (LSUHSC-NO) Chart data will be collected retrospectively back to one year from date ...

Phase N/A

Fixed-Free HTN Trial

Patients who have uncontrolled hypertension and who require triple therapy will be randomized to receive: Fixed combination containing 3 anti-hypertensive drugs: losartan 100 mg + amlodipin 5 mg + hydrocholorothiazide 12.5 mg one tab/day Or any other therapy decided by the treating physician containing three anti-hypertensive agents but supplied as ...

Phase

A Research Study to Show the Effect of Aprocitentan in the Treatment of Difficult to Control (Resistant) High Blood Pressure (Hypertension) and Find Out More About Its Safety

The purpose of the study is to show the blood pressure lowering effect of aprocitentan, a new drug, when added to other anti-hypertensive drugs of patients with difficult to control (resistant) high blood pressure (hypertension), and to show that blood pressure reduction is kept for long period of time.

Phase

Phase 2b Study of KBP-5074 in Subjects With Uncontrolled Hypertension and Advanced Chronic Kidney Disease

The study will enroll approximately 240 patients, randomized in a 1:1:1 ratio to 1 of 3 treatment groups (80 patients in each group): KBP-5074 0.25 mg once daily (QD), KBP-5074 0.5 mg QD, or placebo QD. Randomization will be stratified to balance enrollment for key variables that may influence safety ...

Phase

Evaluating the Pharmacokinetic Interaction Between AD-2011 and AD-2012

To evaluate the pharmacokinetic Interaction, safety and tolerability of the combination compared with the single administration of AD-2011 and AD-2012.

Phase

Adiposity and Endothelin Receptor Function

The proposed study is designed to investigate the influence of adiposity on ETB receptor function and subsequent vascular responses. The combination of ET-1, ET-3, and the respective ETA and ETB receptor antagonists will be used to provide insight into the mechanisms of ETB receptor dysfunction in the presence of adiposity. ...

Phase N/A